Form 6-K Zhihu Inc. For: Sep 14 Sep 14, 2026 06:09AM

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2026

 

Commission File Number: 001-40253

 

 

 

Zhihu Inc.

(Registrant’s Name)

 

 

 

18 Xueqing Road

Haidian District, Beijing 100083

People’s Republic of China

(Address of Principal... (continue reading...)


Form 6-K Clearmind Medicine Inc. For: Sep 14 Sep 14, 2026 06:09AM

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of: September 2026

 

Commission file number: 001-41557

 

CLEARMIND MEDICINE INC.

(Translation of registrant’s name into English)

 

101 – 1220 West 6th Avenue

Vancouver, British Columbia

(Address of principal executive offices)

 

... (continue reading...)


Form F-3 Radiopharm Theranostics Sep 14, 2026 06:09AM

As filed with the Securities and Exchange Commission on September 14, 2026

Registration No. 333-            

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM F-3

 

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

 

Radiopharm Theranostics Limited

(Exact name of registrant as specified in its charter)

 

Not Applicable

(Translation of registrant’s name into English)

 

Australia   Not... (continue reading...)
Form 424B2 JPMORGAN CHASE & CO Sep 14, 2026 06:08AM

The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

Subject to completion dated September 11, 2026

Pricing supplement

To prospectus dated April 17, 2026,

prospectus supplement dated April 17, 2026 and

product supplement no. 1-I... (continue reading...)


Form 424B2 JPMORGAN CHASE & CO Sep 14, 2026 06:08AM The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. Subject to completion dated September 11, 2026 September , 2026 Registration Statement Nos. 333-293684 and 333-293684-01; Rule 424(b)(2) Pricing supplement to product supplement no. 3-I dated... (continue reading...)

More SEC Filings

View Older Stories

Sep 14, 2026 06:07AM Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
Sep 14, 2026 06:07AM Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
Sep 14, 2026 06:06AM Form 6-K Li Auto Inc. For: Sep 14
Sep 14, 2026 06:06AM Form D/A Sage Partners Alpha 1
Sep 14, 2026 06:05AM Form SCHEDULE 13G/A Grab Holdings Ltd Filed by: TOYOTA MOTOR CORP/
Sep 14, 2026 06:05AM Form 3 Polar Power, Inc. For: Aug 17 Filed by: Ahern Jim
Sep 14, 2026 06:05AM Form SCHEDULE 13G Safe Pro Group Inc. Filed by: FROST PHILLIP MD ET AL
Sep 14, 2026 06:04AM Form 8-K WhiteFiber, Inc. For: Sep 14
Sep 14, 2026 06:03AM Form 6-K PRUDENTIAL PLC For: Sep 14
Sep 14, 2026 06:03AM Form S-1/A Electra Therapeutics,
Sep 14, 2026 06:03AM Form 4 Alibaba Group Holding For: Sep 10 Filed by: Wu Yongming
Sep 14, 2026 06:03AM Form 1-SA McQueen Labs Series, For: Jun 30
Sep 14, 2026 06:03AM Form C/A Oravanti Ventures Inc
Sep 14, 2026 06:03AM Form S-3ASR Tyra Biosciences, Inc.
Sep 14, 2026 06:03AM Form DEF 14C SHARING ECONOMY INTERNAT For: Sep 14
Sep 14, 2026 06:03AM Form 424B2 Jefferies Financial Grou
Sep 14, 2026 06:02AM Form 6-K WOODSIDE ENERGY GROUP For: Sep 14
Sep 14, 2026 06:03AM Form 15-12G Apogee Therapeutics,
Sep 14, 2026 06:02AM Form 8-K Artificial Intelligence For: Sep 14
Sep 14, 2026 06:02AM Form EFFECT ACCURAY INC
Sep 14, 2026 06:02AM Form 6-K Biophytis SA For: Sep 11
Sep 14, 2026 06:02AM Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
Sep 14, 2026 06:02AM Form 6-K KE Holdings Inc. For: Sep 14
Sep 14, 2026 06:02AM Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 11 Filed by: Heshmatpour Amir F
Sep 14, 2026 06:02AM Form EFFECT Eightco Holdings Inc.
Sep 14, 2026 06:02AM Form EFFECT Wheeler Real Estate Inve
Sep 14, 2026 06:02AM Form 6-K Nanobiotix S.A. For: Sep 14
Sep 14, 2026 06:02AM Form EFFECT Strategic Storage Trust
Sep 14, 2026 06:02AM Form EFFECT VS MEDIA Holdings Ltd
Sep 14, 2026 06:02AM Form EFFECT Indivior Pharmaceuticals
Sep 14, 2026 06:02AM Form 8-K ORACLE CORP For: Sep 12
Sep 14, 2026 06:02AM Form 6-K NOMURA HOLDINGS INC For: Sep 14
Sep 14, 2026 06:02AM Form EFFECT Nasus Pharma Ltd
Sep 14, 2026 06:02AM Form EFFECT ENIGMATIG LTD
Sep 14, 2026 06:02AM Form EFFECT First Breach, Inc.
Sep 14, 2026 06:02AM Form EFFECT Regan Capital Alternativ
Sep 14, 2026 06:02AM Form SUPPL THOMSON REUTERS CORP
Sep 14, 2026 06:02AM Form 424B2 GOLDMAN SACHS GROUP INC
Sep 14, 2026 06:02AM Form 424B5 Thomson Reuters (Tax & Filed by: West Publishing Corp
Sep 14, 2026 06:02AM Form EFFECT Can-Fite BioPharma Ltd.
Sep 14, 2026 06:02AM Form 1-SA LianSheng Group Inc For: Jun 30
Sep 14, 2026 06:02AM Form EFFECT Calisa Acquisition Corp
Sep 14, 2026 06:02AM Form S-1/A Eaglesky Acquisition
Sep 14, 2026 06:02AM Form 6-K Cellectis S.A. For: Sep 14
Sep 14, 2026 06:02AM Form 6-K Caledonia Mining Corp For: Sep 14
Sep 14, 2026 06:02AM Form EFFECT Can-Fite BioPharma Ltd.
Sep 14, 2026 06:02AM Form 485BXT Spinnaker ETF Series
Sep 14, 2026 06:02AM Form FWP BANK OF MONTREAL /CAN/ Filed by: BANK OF MONTREAL /CAN/
Sep 14, 2026 06:02AM Form FWP BARCLAYS BANK PLC Filed by: BARCLAYS BANK PLC
Sep 14, 2026 06:02AM Form D Aspire Group Ltd.
View Older Stories